TYRA Live signaler | Maksimer profitt med Getagraph.com

KJøP 111321 min ago

@ $19.02

Utstedt: 12 feb 2024 @ 18:36

Avkastning: -13.51%

Forrige signal: feb 12 - 15:39

Forrige signal: Selg

Avkastning: -0.94 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer...

Stats
Dagens volum	115 945
Gjennomsnittsvolum	146 504
Markedsverdi	864.02M
EPS	$0 ( 2024-03-27 )
Neste inntjeningsdato	( $-0.460 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.15
ATR14	$0.0240 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Fuhrman Alan	Buy	932	Common Stock
2024-03-15	Tada Hiroomi	Buy	1 968	Common Stock
2024-03-15	Harris Todd	Buy	1 880	Common Stock
2024-03-11	Bensen Daniel	Sell	200	Common Stock
2024-03-06	Bensen Daniel	Sell	1 733	Common Stock

INSIDER POWER
85.25
Last 100 transactions
Buy: 6 273 982 \| Sell: 603 690

Volum Korrelasjon

Lang: 0.05 (neutral)

Kort: 0.47 (neutral)

Signal:(50.964) Neutral

Tyra Biosciences, Inc. Korrelasjon

10 Mest positive korrelasjoner
DRNA	0.954
SUMO	0.939
IOAC	0.936
OCSL	0.935
IRMD	0.932
CMPI	0.922
XM	0.921
ALBO	0.92
SLMBP	0.919
PRAA	0.915

10 Mest negative korrelasjoner
GMII	-0.933
WASH	-0.921
AFYA	-0.913
EAR	-0.897
TRMK	-0.897
XPDI	-0.894
GOOD	-0.893
ALXO	-0.888
TUEM	-0.888
AVIR	-0.884

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Tyra Biosciences, Inc. Korrelasjon - Valuta/Råvare

-0.06
( neutral )

-0.57
( weak negative )

0.00
( neutral )

-0.65
( moderate negative )

0.80
( moderate )

0.15
( neutral )

Tyra Biosciences, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-353 000 (0.00 %)
EPS:	$-1.620

FY	2023
Omsetning:	$0
Bruttogevinst:	$-353 000 (0.00 %)
EPS:	$-1.620

FY	2022
Omsetning:	$0
Bruttogevinst:	$-296 000 (0.00 %)
EPS:	$-1.230

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.910

Financial Reports:

No articles found.

Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Sanntidsoppdatering for Tyra Biosciences, Inc. [TYRA]

Upcoming Earnings Alert